10-Q – Page 135 – China Stock Advice

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x March 31, 2013

[FORM 10-Q (Mark One) x March 31, 2013 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated.ted: May15, 2013 Ronghua Wang Chief Executive Officer ex32-1.htm 4 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated.ted: May15, 2013 Qinghua Liu Interim Chief Financial Officer (principal financial officer) ex32-2.htm 5 EX-32.2]

By info| 2016-02-07T15:19:31+00:00 May 15th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 10-Q, 2013-05-15, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321033113.htm]

By info| 2016-03-03T16:56:27+00:00 May 14th, 2013|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2013-05-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x March 31, 2013

[FORM 10-Q (Mark One) x March 31, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321033113.htm]

By info| 2016-03-03T16:57:38+00:00 May 14th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2013-05-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

THTI [THT Heat Transfer Technology] 10-Q: FORM 10-Q (Mark One) [X] For the quarterly

[FORM 10-Q (Mark One) [X] For the quarterly period ended: March 31, 2013 [ ] For the transition period from ____________to _____________ THT HEAT TRANSFER TECHNOLOGY, INC. Nevada 20-5463509 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) THT Industrial Park No. 5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 Peoples Republic of China 86-434-3265241 (Former] [CERTIFICATIONS I, Guohong Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of THT Heat Transfer Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Jianjun He, certify that: 1. I have reviewed this quarterly report on Form 10-Q of THT Heat Transfer Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Guohong Zhao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Zhigang Xu Chief Financial Officer (Principal Financial Officer)]

By info| 2016-03-22T17:19:28+00:00 May 14th, 2013|Categories: Chinese Stocks, THTI, Webplus ver|Tags: 0001375686, 10-Q, 2013-05-14, 3443, FABRICATED PLATE WORK (BOILER SHOPS), THTI|0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] 10-Q: (Original Filing)

[] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q I, Qizhou Wu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q I, Jie Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Qizhou Wu President and Chief Executive Officer] [18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jie Li Chief Financial Officer]

By info| 2016-03-28T15:57:41+00:00 May 14th, 2013|Categories: CAAS, Chinese Stocks, SEC Original|Tags: 0001157762, 10-Q, 2013-05-14, 3714, CAAS, MOTOR VEHICLE PARTS and ACCESSORIES|0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] 10-Q:

[] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q I, Qizhou Wu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q I, Jie Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Qizhou Wu President and Chief Executive Officer] [18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jie Li Chief Financial Officer]

By info| 2016-03-28T15:59:10+00:00 May 14th, 2013|Categories: CAAS, Chinese Stocks, Webplus ver|Tags: 0001157762, 10-Q, 2013-05-14, 3714, CAAS, MOTOR VEHICLE PARTS and ACCESSORIES|0 Comments

SCOK [Hongli Clean Energy Technologies] 10-Q:

[] [CERTIFICATION I, Jianhua Lv, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of SinoCoking Coal and Coke Chemical Industries, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION I, Zan Wu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of SinoCoking Coal and Coke Chemical Industries, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Jianhua Lv, Chief Executive Officer] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zan Wu, Chief Financial Officer (Principal Financial and Accounting Officer)]

By info| 2016-03-30T06:52:56+00:00 May 14th, 2013|Categories: Chinese Stocks, SCOK, Webplus ver|Tags: 0001099290, 10-Q, 2013-05-14, 3312, SCOK, STEEL WORKS, BLAST FURNACES ROLLING MILLS (COKE OVENS)|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Nevada 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:May 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) cphi10qex321033113.htm]

By info| 2016-02-07T21:39:50+00:00 May 14th, 2013|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2013-05-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x March 31, 2013

[FORM 10-Q (Mark One) x March 31, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Nevada 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:May 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) cphi10qex321033113.htm]

By info| 2016-02-07T21:40:28+00:00 May 14th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2013-05-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

KNDI [Kandi Technologies] 10-Q: (Original Filing)

[FORM 10-Q [ x ] For the quarterly period ended March 31, 2013 or [ ] For the transition period from ______to______ KANDI TECHNOLOGIES GROUP, INC. Delaware 90-0363723 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) Post Code 321016 Jinhua City Industrial Zone (86 - 579) 82239856 Large accelerated filer [ ] Accelerated filer [ ]] [The Joint Venture Agreement of Establishment of Zhejiang Kandi Electric Vehicles Co., Ltd. by Shanghai Maple Guorun Automobile Co., Ltd., a subsidiary of and Zhejiang Kandi Vehicles Co., Ltd., a subsidiary of Kandi Technologies Group, Inc. Nasdaq: KNDI March 22, 2013 1 Table of Contents 1. Parties of the Joint Venture 7 1.1 Parties of the Joint Venture 7 1.2] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zhu Xiaoying, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.]

By info| 2016-03-18T13:51:43+00:00 May 14th, 2013|Categories: Chinese Stocks, KNDI, SEC Original|Tags: 0001316517, 10-Q, 2013-05-14, 3711, KNDI, MOTOR VEHICLES and PASSENGER CAR BODIES|0 Comments